Hunan Erkang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
On April 29, 2026, the Company received a notification from its controlling shareholder, Mr. Shuai Fangwen, regarding the release of part of his pledged shares. The relevant details are announced as follows:
1. Basic Information on the Release of Pledged Shares
| Shareholder Name | Controlling Shareholder or Largest Shareholder | Number of Shares Released (shares) | Percentage of Shares Held (%) | Percentage of Total Shares (%) | Start Date | Release Date | Pledgee |
|---|---|---|---|---|---|---|---|
| Shuai Fangwen | Yes | 20,000,000 | 2.34 | 0.97 | March 27, 2019 | April 28, 2026 | Hunan Trust Co., Ltd. |